Association of antipsychotic and antidepressant drugs with Q-T interval prolongation (Q37171571)

18 August 2017

1 reference

title

Association of antipsychotic and antidepressant drugs with Q-T interval prolongation (English)

1 reference

18 August 2017

Wesley R Zemrak

1

1 reference

18 August 2017

George A Kenna

series ordinal

2

1 reference

18 August 2017

publication date

1 June 2008

1 reference

American Journal of Health-System Pharmacy

18 August 2017

published in

1 reference

18 August 2017

volume

65

1 reference

18 August 2017

issue

11

1 reference

18 August 2017

page(s)

1029-1038

1 reference

Prolonged QTc interval and risk of sudden cardiac death in a population of older adults

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070279

QTc prolongation and sudden cardiac death: the association is in the detail

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070279

Adverse cardiovascular events in antidepressant trials involving high-risk patients: a systematic review of randomized trials.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070279

Frequency of high-risk use of QT-prolonging medications

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070279

Antipsychotics and the risk of sudden cardiac death

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070279

Cardiac arrest and ventricular arrhythmia in patients taking antipsychotic drugs: cohort study using administrative data

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070279

Psychotropic drugs and alcohol: Pharmacokinetic and pharmaco dynamic interactions

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070279

Torsade de pointes induced by psychotropic drugs and the prevalence of its risk factors

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070279

Electrophysiological remodeling in hypertrophy and heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070279

Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070279

Sex differences in ventricular repolarization: from cardiac electrophysiology to Torsades de Pointes

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070279

Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070279

Psychotropic drugs, cardiac arrhythmia, and sudden death

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070279

Cardiovascular side effects of new antidepressants and antipsychotics: new drugs, old concerns?

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070279

Cyclic antidepressants and the risk of sudden cardiac death

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070279

Drugs and the QT interval - caveat doctor

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070279

Inhibitory actions of the selective serotonin re-uptake inhibitor citalopram on HERG and ventricular L-type calcium currents

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070279

Predicting drug-hERG channel interactions that cause acquired long QT syndrome.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070279

The antidepressant drug fluoxetine is an inhibitor of human ether-a-go-go-related gene (HERG) potassium channels

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070279

Drug-induced long QT syndrome: hERG K+ channel block and disruption of protein trafficking by fluoxetine and norfluoxetine.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070279

Prolonged QT interval and torsades de pointes caused by the combination of fluconazole and amitriptyline

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070279

Intraventricular conduction delay after bupropion overdose

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070279

Fluoxetine and ventricular torsade — is there a link?

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070279

Fluoxetine (Prozac) as a cause of QT prolongation

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070279

QTc prolongation and torsades de pointes in an elderly woman taking fluoxetine.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070279

Cardiac conduction disturbances after an overdose of nefazodone and gabapentin

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070279

Nefazodone-associated torsade de pointes

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070279

Treatment of corticosteroid-induced mood changes with olanzapine

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070279

Bupropion overdose: QTc prolongation and its clinical significance

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070279

Olanzapine prolongs cardiac repolarization by blocking the rapid component of the delayed rectifier potassium current

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070279

Risperidone reduces K+ currents in human atrial myocytes and prolongs repolarization in human myocardium.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070279

Risperidone prolongs cardiac repolarization by blocking the rapid component of the delayed rectifier potassium current

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070279

hERG K+ channel blockade by the antipsychotic drug thioridazine: An obligatory role for the S6 helix residue F656.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070279

High affinity blockade of the HERG cardiac K(+) channel by the neuroleptic pimozide

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070279

Inhibition of the current of heterologously expressed HERG potassium channels by imipramine and amitriptyline

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070279

A comparison of the receptor binding and HERG channel affinities for a series of antipsychotic drugs

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070279

Corrected QT interval prolongation associated with intravenous haloperidol in acute coronary syndromes

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070279

Haloperidol-induced torsade de pointes

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070279

Haloperidol-induced torsades de pointes

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070279

QTc prolongation and high-dose olanzapine.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070279

QT interval prolongation associated with quetiapine (Seroquel) overdose

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070279

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070279

Quetiapine for olanzapine-induced galactorrhea

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070279

Cardiotoxicity associated with intentional ziprasidone and bupropion overdose

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070279

Effects of antipsychotic drugs on I(to), I (Na), I (sus), I (K1), and hERG: QT prolongation, structure activity relationship, and network analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070279

Effects of encainide, flecainide, imipramine and moricizine on ventricular arrhythmias during the year after acute myocardial infarction: the CAPS

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070279

Tricyclic antidepressants, QT interval prolongation, and torsade de pointes

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070279

QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070279

Torsades de Pointes associated with intravenous haloperidol in critically ill patients

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070279

Antipsychotic-related QTc prolongation, torsade de pointes and sudden death

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070279

A randomized evaluation of the effects of six antipsychotic agents on QTc, in the absence and presence of metabolic inhibition

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070279

Drug-induced QT interval prolongation after ciprofloxacin administration in a patient receiving olanzapine

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070279

Sudden cardiac death and antipsychotic drugs: do we know enough?

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070279

Pharmacokinetic factors in the adverse cardiovascular effects of antipsychotic drugs

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070279

Interaction of Chlorpromazine and Nortriptyline in Patients with Schizophrenia

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070279

Electrophysiologic studies of perphenazine and protriptyline in a patient with psychotropic drug-induced ventricular fibrillation

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070279

Ventricular tachycardia associated with desipramine and thioridazine

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070279

QT interval prolongation related to psychoactive drug treatment: a comparison of monotherapy versus polytherapy.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070279

QT interval analysis in patients with chronic liver disease: a prospective study

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070279

Alcoholic liver cirrhosis complicated with torsade de pointes during plasma exchange and hemodiafiltration

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070279

Q-T interval prolongation in cirrhosis: prevalence, relationship with severity, and etiology of the disease and possible pathogenetic factors

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070279

Importance of hepatitis C coinfection in the development of QT prolongation in HIV-infected patients.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070279

31 March 2020

Identifiers

DOI

10.2146/AJHP070279

1 reference

18 August 2017

1 reference